How Strategic Collaborations Transform Clinical Diagnostics
Impossible d'ajouter des articles
Désolé, nous ne sommes pas en mesure d'ajouter l'article car votre panier est déjà plein.
Veuillez réessayer plus tard
Veuillez réessayer plus tard
Échec de l’élimination de la liste d'envies.
Veuillez réessayer plus tard
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
How Strategic Collaborations Transform Clinical Diagnostics
-
Lu par :
-
De :
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss recent industry news and how collaborations are helping drive transformation in clinical diagnostics. Together, they explore:
- Protecting Access to Medicare Act (PAMA) delay (01:09): Dr. Morice shares what the latest delay of PAMA means for laboratories.
- FDA guidance on wearables (02:23): Learn about recent FDA guidance that allows more non‑invasive wearables to be classified as wellness devices.
- Collaboration as a driver of innovation (06:20): Discover why collaboration is critical to advancement in clinical diagnostics.
Note: Information in this post was accurate at the time of its posting.
Resources
- Groundbreaking collaborations
- Mary Jo Williamson offers four steps to maximize collaboration benefits
- Dr. Bill Morice shares how a platform for collaboration transforms diagnostics
- “Answers From the Lab” podcast: “Forging Collaborations That Deliver Better Outcomes”
adbl_web_anon_alc_button_suppression_t1
Aucun commentaire pour le moment
